General conditions of use and legal notices
Anyone accessing the site https:// alderaanbiotechnology.com/ hereinafter the “Site” must, prior to any consultation of the information on the Site, be aware of these general conditions of use. Use of the Site implies acceptance of these general conditions of use and a commitment to comply with their provisions. The general conditions of use can be modified at any time, without notice, we advise you to consult them regularly. https:// alderaanbiotechnology.com is a site published by Alderaan Biotechnology, whose head office is located at 4 rue Thénard, 75005 Paris, recognized as being a company under SIREN number: 830 990 073.
The webmastering of the Site is provided by the MLCOM communication agency
The site host is OVH a simplified joint stock company with a single shareholder with a capital of 10,174,560 euros, whose head office is located at 2 rue Kellermann – 59100 Roubaix – France, registered in the Lille Trade and Companies Register under the number 42476141900045.
OBJECTIVES AND RECIPIENTS OF THE SITE
The Site aims to present Alderaan biotechnology programs related to the elimination of Regulatory T cells and to the hyper activation of Natural Killer cells in the tumor microenvironment.
ACCESS TO THE SITE
Alderaan biotechnology reserves the right to terminate, modify, suspend, restrict or interrupt access to all or part of the Site, without notice.
NATURE OF CONTENT
The information on the Site is produced by Alderaan biotechnology.
© Alderaan biotechnology 2020– All reproduction and representation rights reserved, including for downloadable documents and iconographic and photographic representations. None of this information may be reproduced, modified, transmitted, redistributed, translated, sold, exploited or reused for commercial purposes. Any of the above conditions can be waived if you have permission from the site owner.
LINKS TO OTHER SITES
The Site is exclusively financed by Alderaan biotechnology. This Site does not host any form of advertising.
LIMITATIONS OF LIABILITY
Alderaan biotechnology makes its best efforts to regularly update the information on its Site. However, despite all the care and attention given to the selection of sources and to the drafting of the content and information published on the Site, Alderaan biotechnology cannot guarantee the accuracy and completeness of the information contained on the Site. . Certain inaccuracies, inaccuracies, errors, omissions or even data entered without the knowledge and without the authorization of Alderaan biotechnology may nevertheless appear. In these circumstances, Alderaan biotechnology cannot be held liable for any direct or indirect damage of any kind whatsoever suffered by a User of the Site as a result (in particular and without restriction loss of data / programs, loss of software, interruption of activity, etc.) of the consultation of its Site and / or of the use which will be made of it by the User of the Site or of the use of the information provided on the Site except for gross negligence or willful misconduct which it is exclusively attributable and proven by the one who invokes it.Where applicable, and for any document the content of which is the sole responsibility of its author, the name and position of the latter is mentioned in the document concerned.Alderaan biotechnology and its host may, at any time, modify or interrupt, temporarily or permanently, all or part of the Site in order to carry out maintenance and / or make improvements and / or modifications to the Site. Alderaan biotechnology declines all responsibility for any modification, suspension or interruption of the Site.The Site and its content are governed by French law, and any dispute relating to it is subject to the jurisdiction of the courts of France.
CONVENTION ON PROOF
The computerized registers kept in the computer systems of ARIIS or of a company appointed by Alderaan biotechnology under reasonable security conditions, will be considered as proof of communications and the various transmissions of information between Internet users and Alderaan biotechnology. Data conservation and archiving are carried out on a reliable and durable medium in accordance with article 1379 of the Civil Code.